North America Protein A Resins Market Share to Steer at 8.8% CAGR to 2026

Published Date: 2020-02-11

Request a sample

According to the Graphical Research new growth forecast report titled “North America Protein A Resins Market Share By Matrix Type (Agarose-based Matrix, Glass or Silica Gel-based Matrix, Organic Polymer-based Matrix), By Application (Immunoprecipitation, Antibody Purification), By Product (Natural Protein A, Recombinant Protein A), By End-use (Biopharmaceutical Companies, Clinical Research Laboratories, Academic Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook (U.S., Canada)”, Estimated To Exceed USD 415.0 Million By 2026.

Growing demand for monoclonal antibodies will boost the adoption of Protein A resins in North America over the forecast years. Protein A resins offer improved, standard and economic method of purification of biological samples. Antibodies form one of the major and is rapid growing class of protein pharmaceuticals. Due to physiological, pharmacological, and structural properties, antibody fragments bid novel biopharmaceutical prospects. Thus, increasing focus on monoclonal antibodies coupled with high preference for protein A resins will augment the market growth.

Rapid rise in the use of chromatography for identification of vitamins and additives is estimated to spur protein A resins market growth during the analysis period. Chromatography is superlative technique for separation of biological and chemical components in comparison with conventional techniques. Also, it has applications in forensic science. Broad range of applications and high outcome rate will drive the industry growth. However, high cost associated with protein A resins may hamper the industry growth in forthcoming years.

Antibody purification application segment accounted for more than 75% revenue share in 2019. Protein A kits are developed for purification of antibodies for structural and diagnostic studies. They are also used as molecular probes for research and development activities. Monoclonal antibodies exhibit remarkable results in the management of chronic conditions such as cancer and rheumatoid arthritis. Thus, wide applications and benefits of protein A resins for antibody purification will expand the segmental growth in the forthcoming years.

Natural protein A resins market held more than USD 83.5 million revenue size in 2019. Natural A proteins are highly base sensitive. As a result, a costlier alternative. However, natural protein A resins have high capacity and efficiency for processing of monoclonal antibodies and thus its benefits will contribute to high segment growth.

Organic polymer-based matrix segment is estimated to proceed at 10.2% CAGR over the forecast timeframe. Modification of organic polymers through the integration of extracts yields, with limited exemptions, multiphase systems including the additive implanted in a continuous polymer composites drives the segment growth over the forecast period. The benefits for using additives includes property modification or improvement, overall cost decrease, refining and monitoring of processing characteristics, thus increasing the segmental growth.

Adoption of protein A resins in clinical research laboratories will increase at 9.7% CAGR during the projection period. Numerous clinical trials for antibody-based therapeutics coupled with increase healthcare research spending will drive the segment share over the forecast period. Several biopharmaceutical companies prefer towards laboratories to purify antibodies using to achieve accurate results. Thus, with increasing adoption of protein A resins in chromatography and research, the segment will foresee robust growth.

North America protein A resins market was led by U.S. protein A resins market and is estimated to show a positive trend throughout the projection period. Canada protein A resins business is forecasted to proceed at 8.5% CAGR across the forecast timeframe. Increasing drug development activities due to growing incidence of chronic diseases will influence market growth. Furthermore, expanding applications of immunotherapy will augment the Canadian protein A resins business growth in future.

Major market players in North America protein A resins market are Thermo Fisher Scientific, EMD Millipore, GE Healthcare, and Bio-Rad Laboratories among other industry participants. These market players are undertaking strategies such as technology advancement and inorganic growth strategies to strengthen market presence and company expansion. For instance, in September 2017, GE Healthcare launched new MabSelect PrismA protein A chromatography resin, aimed at expanding their product and cleint base.

North America Protein A resins Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

North America Protein A Resins Market Forecast, By Matrix Type, 2015 to 2026, (USD Million)

  • Biopharmaceutical Companies
  • Clinical Research Laboratories
  • Academic Research Institutes
  • Contract Research Organizations

North America Protein A Resins Market Share, By Product, 2015 to 2026, (USD Million)

  • Natural Protein A
  • Recombinant Protein A

North America Protein A Resins Market Size, By Application, 2015 to 2026, (USD Million)

  • Immunoprecipitation
  • Antibody Purification

North America Protein A Resins Market Value, By Matrix Type, 2015 to 2026, (USD Million)

  •  Agarose-based Matrix
  • Glass or Silica gel-based Matrix
  • Organic Polymer-based Matrix

The above information is provided for the following region and countries:

  • North America
    • U.S.
    • Canada